Stay a step ahead of cancer.
Every patient.
Every stage of the journey.
CancerIQ helps clinicians identify patients who qualify for screening and diagnostic tests, engage them directly, and guide them to completion — from prevention through survivorship.
The science has never been more powerful.
Precision oncology is transforming what’s possible. But these advances only work when the right patient gets the right test. CancerIQ connects more patients to the screenings and diagnostics that guide their care — so the science reaches the people it was built for.
From eligible to engaged, at scale.
Across screening, risk, treatment, and survivorship, CancerIQ connects more patients to the tests that guide their care — and helps ensure those tests are completed, not just ordered.
2.2×
4.2x
8.9X
One platform guides patients across the full cancer journey.
BEFORE DIAGNOSIS
Precision care before a diagnosis.
CancerIQ identifies individual patient risk and connects each person to the next right step — genetic testing and surveillance for those at higher risk, the right screening test for everyone else — enabling early action that improves outcomes.
Tests: Genetic testing (BRCA, Lynch), polygenic risk, breast MRI, MCED, blood-based colon, blood-based lung, mammography, low-dose CT
IN TREATMENT
Biomarker testing that guides treatment decisions.
Access to information about biomarkers can help clinicians determine which therapy will work — and which won’t. CancerIQ helps drive completion — so the breakthrough reaches the patient who needs it.
Tests: Biomarker & molecular tumor testing, liquid biopsy, MRD
SURVIVORSHIP
Recurrence monitoring for every survivor.
Survivors are prime candidates for MRD and ongoing surveillance. CancerIQ keeps them connected to the diagnostics that help catch recurrence earlier.
Tests: MRD, blood-based recurrence surveillance
Works inside the EHR you already use.
CancerIQ builds on the patient information already in your EHR — family history, biopsies, genetic and lab results, medications — so care teams aren't starting from a blank intake. Patients confirm what's missing instead of repeating their history, and providers see a fuller picture of risk right in the chart, whether they're catching an elevated risk for the first time or keeping a patient in treatment or survivorship on track.
With CancerIQ, care teams don't leave their existing workflow — risk assessment, eligibility, test ordering, care plans, and follow-up all happen inside the EHR. Less manual entry. Fewer redundant questions. Fewer patients who fall through the cracks. Just a more connected way to guide every patient from prevention through survivorship.
The patient impact.
“Finding out of course that it was small and that we caught it early, just made me grateful that I did this. You know if I had waited six more months until my regular mammogram, it (the tumor) could have been much larger by then or it could have been much more significant, so I was really grateful for the plan that was put in place.”
How CancerIQ closes the gap in precision oncology.
CancerIQ automates risk assessment across the patient population, identifying who qualifies for screening and diagnostic tests — across prevention, early detection, treatment, and survivorship — and flags them for outreach.
CancerIQ reaches patients directly — in their language, on their device — with personalized education on their risk, their options, and why a specific test matters, so the next step feels clear, not confusing.
CancerIQ guides patients through completion, so testing doesn’t stop at identification, recommendation, or an unfilled order — a recommendation turns into a result.
CancerIQ stays connected to patients, surfacing next steps, surveillance schedules, and follow-up care so no patient falls through the cracks between appointments.
CancerIQ turns activity into evidence, providing clear insights into clinical outcomes and financial ROI so program leaders can prove value and keep improving.
Meet our founders.
CancerIQ was founded by Feyi Ayodele and Olufunmilayo (Funmi) Olopade, MD with a simple conviction: the science to detect, prevent, and treat cancer should reach every patient who can benefit from it.
Our roots are in genetic testing, where we saw firsthand how connecting the right patients to the right care can change outcomes. That same approach supports patients throughout treatment and survivorship, because every patient deserves a personalized plan, no matter where they are in the cancer journey.
